ATC code C09
| ATC codes |
|---|
| C Cardiovascular system |
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin–angiotensin system |
| C10 Lipid modifying agents |
|
|
ATC code C09 Agents acting on the renin–angiotensin system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C09 is part of the anatomical group C Cardiovascular system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC09.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C09A ACE inhibitors, plain
C09AA ACE inhibitors, plain
- C09AA01 Captopril
- C09AA02 Enalapril
- C09AA03 Lisinopril
- C09AA04 Perindopril
- C09AA05 Ramipril
- C09AA06 Quinapril
- C09AA07 Benazepril
- C09AA08 Cilazapril
- C09AA09 Fosinopril
- C09AA10 Trandolapril
- C09AA11 Spirapril
- C09AA12 Delapril
- C09AA13 Moexipril
- C09AA14 Temocapril
- C09AA15 Zofenopril
- C09AA16 Imidapril
C09B ACE inhibitors, combinations
C09BA ACE inhibitors and diuretics
- C09BA01 Captopril and diuretics
- C09BA02 Enalapril and diuretics
- C09BA03 Lisinopril and diuretics
- C09BA04 Perindopril and diuretics
- C09BA05 Ramipril and diuretics
- C09BA06 Quinapril and diuretics
- C09BA07 Benazepril and diuretics
- C09BA08 Cilazapril and diuretics
- C09BA09 Fosinopril and diuretics
- C09BA12 Delapril and diuretics
- C09BA13 Moexipril and diuretics
- C09BA15 Zofenopril and diuretics
C09BB ACE inhibitors and calcium channel blockers
- C09BB02 Enalapril and lercanidipine
- C09BB03 Lisinopril and amlodipine
- C09BB04 Perindopril and amlodipine
- C09BB05 Ramipril and felodipine
- C09BB06 Enalapril and nitrendipine
- C09BB07 Ramipril and amlodipine
- C09BB10 Trandolapril and verapamil
- C09BB12 Delapril and manidipine
C09BX ACE inhibitors, other combinations
- C09BX01 Perindopril, amlodipine and indapamide
- C09BX02 Perindopril and bisoprolol
- C09BX03 Ramipril, amlodipine and hydrochlorothiazide
- C09BX04 Perindopril, bisoprolol and amlodipine
- C09BX05 Ramipril and bisoprolol
- QC09BX90 Benazepril and pimobendan
C09C Angiotensin II receptor blockers (ARBs), plain
C09CA Angiotensin II receptor blockers (ARBs), plain
- C09CA01 Losartan
- C09CA02 Eprosartan
- C09CA03 Valsartan
- C09CA04 Irbesartan
- C09CA05 Tasosartan
- C09CA06 Candesartan
- C09CA07 Telmisartan
- C09CA08 Olmesartan medoxomil
- C09CA09 Azilsartan medoxomil
- C09CA10 Fimasartan
C09D Angiotensin II receptor blockers (ARBs), combinations
C09DA Angiotensin II receptor blockers (ARBs) and diuretics
- C09DA01 Losartan and diuretics
- C09DA02 Eprosartan and diuretics
- C09DA03 Valsartan and diuretics
- C09DA04 Irbesartan and diuretics
- C09DA06 Candesartan and diuretics
- C09DA07 Telmisartan and diuretics
- C09DA08 Olmesartan medoxomil and diuretics
- C09DA09 Azilsartan medoxomil and diuretics
- C09DA10 Fimasartan and diuretics
C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers
- C09DB01 Valsartan and amlodipine
- C09DB02 Olmesartan medoxomil and amlodipine
- C09DB04 Telmisartan and amlodipine
- C09DB05 Irbesartan and amlodipine
- C09DB06 Losartan and amlodipine
- C09DB07 Candesartan and amlodipine
- C09DB08 Valsartan and lercanidipine
- C09DB09 Fimasartan and amlodipine
C09DX Angiotensin II receptor blockers (ARBs), other combinations
- C09DX01 Valsartan, amlodipine and hydrochlorothiazide
- C09DX02 Valsartan and aliskiren
- C09DX03 Olmesartan medoxomil, amlodipine and hydrochlorothiazide
- C09DX04 Valsartan and sacubitril
- C09DX05 Valsartan and nebivolol
- C09DX06 Candesartan, amlodipine and hydrochlorothiazide
- C09DX07 Irbesartan, amlodipine and hydrochlorothiazide
C09X Other agents acting on the renin–angiotensin system
C09XA Renin-inhibitors
- C09XA01 Remikiren
- C09XA02 Aliskiren
- C09XA52 Aliskiren and hydrochlorothiazide
- C09XA53 Aliskiren and amlodipine
- C09XA54 Aliskiren, amlodipine and hydrochlorothiazide
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ↑ "ATC/DDD Index 2022: code C09". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2022: code QC09". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.